ORGO
NASDAQ
$2.63
Organogenesis Holdings Inc - Class A (ORGO)
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.
Sector:
Healthcare
Hold
Target: $3 (+14.07%)
Market Cap
$320M
FCF 5Y CAGR
+87.05%
Forward P/E
12.67
P/E Ratio
92.15
Price Chart
Valuation
Market Cap$320M
P/E92.15
Forward P/E12.67
P/S0.62
P/B1.23
Profitability
Total Revenue (TTM)$515M
Gross Profit (TTM)$380M
EBITDA$19M
Profit Margin0.5%
Operating Margin-174.7%
EPS$0.03
Financial Health
Free Cash Flow Yield5.33%
Growth & Risk
EPS 5Y CAGR-40.50%
Revenue 5Y CAGR+6.31%
FCF 5Y CAGR+87.05%
Beta (5Y)1.93
Sharpe Ratio-0.39